Medical cannabis manufacturer Cilo Cybin is set to make its debut on the JSE’s Alternative Exchange before the end of September as it focuses on export opportunities into Europe and Australia. 

The company, which has a licence to cultivate, process, package, label and sell medical cannabis products, initially planned to list late last year but was unable to reach the minimum capital requirement for a listing as a special-purpose acquisition company. ..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.